Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Profound Medical Corp. (NASDAQ: PROF)
PROF Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
51.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-8.40%
PROF Stock Analysis
PROF
PE Ratio:
PROF
PEG Ratio:
Not Available
PROF
Forward EPS Growth (12 month):
0.00%
PROF
PS Ratio:
14.5
PROF
PSG Ratio:
0.2
PROF
Forward Revenue Growth (12 month):
64.10%
PROF Articles
No data was found